PharmaEssentia
6446Drug Manufacturers - Specialty & Generic
NT$1,240.00+3.33%As of Oct 29vs prior close
- Market cap
- $15.8B
- P/E (TTM)
- 69.1×
- P/E (FY1)
- 46.1×
- From 52W high
- −21.77%
- EPS (LTM)
- NT$17.37
- Revenue (LTM)
- NT$20.8B
- Net margin
- 36.76%
- Dividend yield
- 0.12%
Nomior Score
78
Vanguard CompounderTop 3% of the scored universe
Growth89
Quality67
Value30
Momentum91
Resilience55
Growth
+75.71%revenue a year over 3 fiscal years
YE22 NT$2.9BLTM NT$20.8B
Connections
Revenue to profitYE25
32% of revenue became net profit, up 2 pts on a year.